Evidence map›Paper›PMID 38129544›Full record

ArticleCancer causes & control : CCC2024

Associations between pregnancy-related factors and birth characteristics with risk of rare uterine cancer subtypes: a Nordic population-based case-control study.

Jazmine Abril, Britton Trabert, Rebecca Troisi, Tom Grotmol, Anders Ekbom, Anders Engeland, Mika Gissler, Ingrid Glimelius, Laura Madanat-Harjuoja, Anne Gulbech Ording and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cancer causes & control : CCC, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 5 countries.

Jazmine AbrilSchool of Medicine, University of Utah, Salt Lake City, UT, USA.
Britton TrabertDepartment of Obstetrics and Gynecology, Huntsman Cancer Institute at the University of Utah, University of Utah, 2000 Circle of Hope Dr. Research South #4719, Salt Lake City, UT, 84112, USA. britton.trabert@hci.utah.edu.ORCID https://orcid.org/0000-0002-1539-6090
Rebecca TroisiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Tom GrotmolCancer Registry of Norway, Oslo, Norway.
Anders EkbomClinical Epidemiology Division, Department of Medicine, Karolinska Institute, Stockholm, Sweden.
Anders EngelandDepartment of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Mika GisslerDepartment of Knowledge Brokers, THL Finnish Institute for Health and Welfare, Helsinki, Finland.
Ingrid GlimeliusClinical Epidemiology Division, Department of Medicine, Karolinska Institute, Stockholm, Sweden.
Laura Madanat-HarjuojaFinnish Cancer Registry, Helsinki, Finland.
Anne Gulbech OrdingDepartment of Clinical Epidemiology, Aarhus University, Aarhus, Denmark.
Henrik Toft SørensenDepartment of Clinical Epidemiology, Aarhus University, Aarhus, Denmark.
Steinar TretliCancer Registry of Norway, Oslo, Norway.
Tone BjørgeCancer Registry of Norway, Oslo, Norway.
Cancer Registry of Norway · NOAarhus University · DKKarolinska Institutet · SEUniversity of Utah · USNational Institutes of Health · USNorwegian Institute of Public Health · NOUniversity of Helsinki · FIUppsala University · SE

Funding

Early Life Exposures and Subsequent Cancer RiskZIACP010168 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI GIERACH, GRETCHEN · 2009 to 2025
$40.9M
Intramural NIH HHS ZIA CP010168Swedish Cancer Society CAN 2016/440
6 · The paper itself

Abstract

purposeUterine sarcomas are a rare group of uterine malignancies. Due to the low incidence and changes in uterine sarcoma classification, risk factors are not well characterized. Our objective was to evaluate risk factors for uterine sarcoma and compare risk factors between uterine sarcoma, malignant mixed Mullerian tumors (MMMTs), and type I endometrial carcinomas.

methodsThis nested case-control study utilized linked data from population-based medical birth and cancer registries in Denmark, Finland, Norway, and Sweden. Up to 10 controls were matched on country and birth year for each uterine cancer case. Using multivariable adjusted multinomial logistic regression, estimates of the associations between pregnancy-related factors and risk of uterine sarcoma, MMMTs, and type I endometrial carcinomas were determined.

resultsHaving a very-low-birth-weight infant (< 1500 vs. 2500-3999 g: OR [95% CI] 2.83 [1.61-4.96]) was associated with an increased risk of uterine sarcoma. Whereas, having a more recent pregnancy was associated with reduced risks of MMMT (< 10 vs. ≥ 30 years: 0.66 [0.20-2.23]) and type 1 endometrial carcinomas (0.35 [0.30-0.41]) but not uterine sarcomas (1.33 [0.90-1.98], p-heterogeneity < 0.01).

conclusionOur study provides evidence that risk factors for uterine sarcoma and MMMT, previously grouped with uterine sarcomas, vary substantially. Additionally, MMMT and type I endometrial carcinomas are more similar than uterine sarcoma in that pregnancy complications like gestational hypertension and preeclampsia were associated with reduced risks of both but not uterine sarcoma, suggesting different etiologies.

Indexed as

SarcomaUterine NeoplasmsAdultAgedCase-Control StudiesDenmarkFemaleFinlandHumansMiddle AgedNorwayPregnancyRegistriesRisk FactorsScandinavian and Nordic CountriesSwedenMalignant mixed mullerian tumorsPregnancy-related factorsRiskType I endometrial cancerUterine sarcoma

Identifiers

PMID38129544
PMCPMC11441445
OpenAlexW4390079425

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.